TAK-041: Clinical Trials

1 trial of TAK-041, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow TAK-041: new trials by email Literature Review of TAK-041 trials Research Report on TAK-041

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study
TAK-041, TAK-041 Placebo - Healthy Volunteers, Schizophrenia
Phase 1CompletedNeurocrine Biosciences1142016-05-092021-03-19

Conditions studied

Schizophrenia (1)

Sponsors

Neurocrine Biosciences (1)

Countries

United States (1)

Results publications

PMID 35277995